Enter your login e-mail to the account
Search
- Nová perorální antidiabetika
doc. MUDr. Tomáš Sechser, CSc.
(1/2004, clearly ) - Classification of dyslipoproteinaemias: Part II – Secondary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(6/2009, Topic of the year ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(4/2011, Drugs & drug classes ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - NOVINKY VO FARMAKOTERAPII: KATEGORIZÁCIA OD 1. OKTÓBRA 2008
Ing. Mgr.Dagmar Hroncová
(9/2008, Informations ) - Preoperative assessment in outpatient department of general practitioner
doc. MUDr. Katarína Gazdíková, PhD.
(2/2014, General Medicine ) - Efficiency and safety of linagliptin – relevance to clinical practice
doc. MUDr. Martin Prázný, CSc., Ph.D., MUDr. Jan Šoupal
(2/2014, Review articles ) - Správa zo XIV. slovenských obezitologických dní s medzinárodnou účasťou
MUC. Michal Pečík
(5/2016, Events ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - Osteoporóza a diabetes mellitus
prof. MUDr. Juraj Payer, CSc., MUDr. Peter Jackuliak, PhD.
(3–4/2013, Topic ) - Pancreatitis
Doc. MUDr. Ladislav Kužela, CSc., MPH
(2/2017, Review articles ) - View of clinical immunology on targeted therapy of psoriasis
doc. MUDr. Martin Hrubiško, PhD.
(5/2012, Interdisciplinary consilium ) - CHRONIC HEART FAILURE AND DIABETES MELLITUS
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Topic ) - NONALCOHOLIC FATTY LIVER DISEASE
MUDr. Martin Zima, PhD.
(4-5/2008, Topic ) - Retardované mononitráty v klinické praxi
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Spectrum ) - IT IS POSSIBLE TO AWAIT FROM „DISEASE MANAGEMENT PROGRAM“ PROFESSIONAL, ECONOMICAL PROFITABLY CARE OF DIABETICS 2. TYPE?
doc. MUDr. Boris Krahulec, CSc., Dr. med. Valerien Sulik
(10/2007, Spectrum ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - Diabesity and cancer
doc. PharmDr. Daniela Mináriková, PhD., MSc., MUDr. Tomáš Harag, doc. MUDr. Peter Minárik, PhD., MSc.
(6/2020, Topic of the year ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - NON-PHARMACOLOGICAL AND PHARMACOLOGICAL POSSIBILITIES IN THERAPY OF OBESE PATIENTS WITH METABOLIC SYNDROME
doc. MUDr. Boris Krahulec, CSc.
(S4/2007, Supplement ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - THERAPY OF DIABETES MELLITUS TYPE 2
MUDr. Juraj Vozár, CSc.
(1/2005, Topic ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - ANAEMIA – DIAGNOSTICS AND TREATMENT
MUDr. Adriana Kafková
(3/2005, clearly ) - THERAPY OF OBESE PATIENTS WITH DIABETES MELLITUS
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Habdáková
(12/2005, Topic ) - PREVENTION OF OBESITY
MUDr. Ivan Majerčák
(12/2005, Topic ) - Metformin – current position in the treatment of type 2 diabetes mellitus and discussed questions of its using
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2015, Review articles ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - INSULIN RESISTANCE AND THE POLYCYSTIC OVARY SYNDROME
prof. MUDr. Ivica Lazúrová, CSc., MUDr. Ingrid Dravecká
(5/2005, Topic ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - SPRÁVA Z V. SYMPÓZIA „ARTÉRIOVÁ HYPERTENZIA: SÚČASNÉ KLINICKÉ TRENDY“, 3. APRÍL 2007, PRAHA (1. časť)
doc. MUDr. Marian Sninčák, CSc., mim. prof.
(6/2007, Events ) - NOVEL INSULINS – ANALOGS IN TYPE 2 DM TREATMENT
doc. MUDr. Emil Martinka, PhD.
(7-8/2008, Topic ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - Diabetes and heart failure
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc.
(1/2014, Review articles ) - Polypharmacy – an untortunate phenomenom not only in psychotherapy
MUDr. Richard Krombholz, MUDr. Hana Drástová
(1/2014, Interdisciplinary consilium ) - OBESITY AND TYPE 2 DIABETES (DIABESITY) – TWO CLOSELY RELATED, PREVENTABLE DISEASES IS THE THERAPY OF OBESITY TOOL FOR PREVENTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES?
MUDr. Ľubomíra Fábryová
(12/2006, Topic ) - Športovanie ako účinný preventívny prvok pred vznikom civilizačných ochorení .
prof. MUDr. Dušan Meško, PhD.
(12/2006, Memorix ) - Prediabetes
Doc. MUDr. Katarína Gazdíková, PhD., MHA, MPH, mim. prof.
(1/2017, Review articles ) - Diabesity, an increasing medical problem – diabetologist must be therefore also an obesitologist
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD.
(4/2016, Topic of the year ) - A patient with newly diagnosed diabetes in the office of general practitioner
MUDr. Eva Papežová
(5/2023, Review articles ) - Possibilities of prevention of type 2 diabetes mellitus in individuals with prediabetic dysglycemias
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2016, Review articles ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic )
- Risks of polypharmacy in psychiatry
MUDr. Richard Krombholz, MUDr. Hana Drástová
(4/2013, Review articles ) - Combined therapy by Alzheimer´s disease
MUDr. Elena Žigová
(1/2013, Original articles & case reports ) - Metabolic syndrome in the context of psychiatric disorders and psychotropic treatment
MUDr. Jozef Dragašek, PhD.
(1/2014, Review articles )
- Diabetes mellitus: současný pohled na patogenezi, klasifikaci a léčbu
prof. MUDr. Michal Anděl, CSc.
(1/2007, From the boundary of neurology ) - Neurological disorders in vitamin B12 deficiency
MUDr. Ivan Martinka
(6/2013, Main topic ) - Use of pregabalin in clinical practice
MUDr. Jolana Rojíčková
(5/2016, Case reports ) - Diabetická polyneuropatia
MUDr. Gabriel Hajaš, PhD.
(3/2018, Main topic ) - Diagnostics and treatment of diabetic autonomic neuropathy
MUDr. Miriam Kozárová, PhD., MUDr. Mária Rašiová, PhD., prof. MUDr. Zuzana Gdovinová, PhD.
(2/2013, From the boundary of neurology )
- Influenza – vaccination is basis of prevention
prof. MUDr. Jiří Beran, CSc.
(6/2010, Review articles ) - CFRD – Cystic Fibrosis Related Diabetes
MUDr. Jaroslava Orosová, MUDr. Nina Bližnáková, MUDr. Ingrid Mikulášová, doc. MUDr. Vladimír Pohanka, PhD., MPH, FCCP
(6/2016, Review articles ) - DIFFERENTIAL DIAGNOSIS OF HYPERGLYCEMIA IN CHILDREN AND ADOLESCENTS
MUDr. Štěpánka Průhová, Ph.D., prof. MUDr. Jan Lebl, CSc.
(6/2005, Review articles )
- SPRÁVA Z 30. SAN ANTONIO BREAST CANCER SYMPOSIUM, 13. – 16. DECEMBER 2007
MUDr. Vladimír Malec
(1/2008, Review articles ) - Pancreatic adenocarcinoma and diabetes mellitus
MUDr. Tatiana Novotná, PhD.
(6/2015, Review articles ) - Aging biology – a brief overview of molecular and cellular mechanisms
Prof. MUDr. Beata Mladosievičová, CSc.
(3/2017, Main topic )
- Pruritus – complete therapy
MUDr. Eva Jašková, MUDr. Petr Taraba
(4/2009, Review articles ) - Brunsting-Perry pemphigoid – clinical case
MUDr. Lubomír Drlík, MUDr. Lenka Slezáková, doc. MUDr. Lumír Pock, CSc.
(4/2012, Original articles & Case reports )
- NOVÁ DOPORUČENÍ (GUIDELINES) PRO LÉČBU DIABETES MELLITUS 2. TYPU
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2007, clearly ) - NOVINKY VO FARMAKOTERAPII: KATEGORIZÁCIA OD 1. OKTÓBRA 2008
Ing. Mgr. Dagmar Hroncová
(3/2008, Drug classes ) - Perorální antidiabetika – současnost
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2009, Drugs & drug classes ) - DIABETES MELLITUS TYPE 2 TREATMENT – ORAL ANTIDIABETIC AGENTS
MUDr. Pavlína Piťhová
(2/2007, clearly ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- The topic of medication non-adherence of geriatric patient and its solution during the individual consultation in a community pharmacy
PharmDr. Jana Šolínová, doc. PharmDr. Josef Malý, Ph.D.
(3/2016, Case reports in pharmacy practice ) - Recent advances in research of Silymarin and its components
Mgr. Jan Soukop, prof. MUDr. Rostislav Večeřa, Ph.D.
(4/2023, Current pharmacotherapy ) - The 42nd Days of Pharmacy with main topic „Diabetes“ – epidemic of the third millennium
doc. RNDr. Magdaléna Fulmeková, CSc.
(2/2016, Events ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(3/2011, New medicinal substances ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Nonprescription drugs and self-medication of diarrhoea and constipation
Mgr. Martin Doseděl, Mgr. Josef Malý, PharmDr. MUDr. Kamil Rudolf
(2/2011, Current pharmacotherapy ) - Contribution to questions of pharmacological treatment in the elderly
MUDr. David Suchý, Ph.D., MUDr. Milan Hromádka, Ph.D.
(4/2011, Current pharmacotherapy ) - Starostlivosť lekárnika o pacientov s diabetom
PharmDr. Marcel Jusko, PhD.
(2/2013, For pharmaceutical laboratory technicians )
- Secondary vasculitides associated to connective tissue diseases and drug-related vasculitides
prof. MUDr. Jozef Rovenský, DrSc., doc. MUDr. Radim Bečvář, CSc.
(3/2010, Review articles ) - Complications of endovascular treatment of abdominal aortic aneurysm
MUDr. Ľubomír Špak, MUDr. Mária Rašiová, PhD., MUDr. Ľudmila Farkašová, PhD.
(1/2015, Original articles & Case reports )
- Metformin-associated lactic acidosis − a case report
MUDr. Ingrid Pirníková, MUDr. Ján Korček, doc. MUDr. Jozef Firment, PhD.
(2/2023, Case reports ) - Lactate and its clearance as a marker of shock after cardiac surgery procedures
doc. MUDr. Pavol Török, CSc., MUDr. Dušan Rybár, MUDr. Janka Beňová, MUDr. Tomáš Grendel, PhD., doc. MUDr. František Sabol, PhD., MPH, MUDr. Peter Čandík, PhD., MPH
(2/2016, Original articles ) - Life – threatening lactic acidosis
MUDr. Katarína Galková, PhD., MUDr. Viera Kissová, PhD., MUDr. Andrej Milovský
(2/2018, Case reports ) - „Unexpected“ cardiogenic shock after propafenone
MUDr. Ladislav Brugoš, MUDr. Tomáš Jankura
(1/2023, Case reports )